• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Database: Ovid MEDLINE(R) <1996 to November Week 3 2008>
Search Strategy:
1flavoxate.mp. or exp FLAVOXATE/ (40)
2(tolterodine or oxybutinin or darifenacin or scopolamine or hyoscyamine or solifenacin or trospium).mp. (3324)
31 or 2 (3352)
4limit 3 to (english language and humans) (1346)
5limit 4 to yr=“2005 – 2009” (608)
6limit 5 to (clinical trial, all or clinical trial or comparative study or controlled clinical trial or evaluation studies or meta analysis or multicenter study or randomized controlled trial) (285)
7observational stud$.mp. (16249)
8exp Cohort Studies/ or cohort$.mp. (464922)
9exp Retrospective Studies/ or retrospective$.mp. (250000)
108 or 7 or 9 (655298)
1110 and 5 (84)
126 or 11 (306)
13from 12 keep 1–306 (306)

From: Appendix B. Search strategy

Cover of Drug Class Review: Agents for Overactive Bladder
Drug Class Review: Agents for Overactive Bladder: Final Report Update 4 [Internet].
McDonagh MS, Selover D, Santa J, et al.
Portland (OR): Oregon Health & Science University; 2009 Mar.
Copyright © 2009, Oregon Health & Science University, Portland, Oregon.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.